Processing 00000000.tx.1: -synuclein gene haplotypes are associated with Parkinsons disease Matt Farrer, Demetrius M. 

Phrase: "-synuclein gene haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "are"

Phrase: "associated with Parkinsons disease Matt Farrer,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0030567:Parkinson Disease [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1521736:Parkinson's Disease [Functional Concept]
   790   C2681933:PARKINSON DISEASE [Gene or Genome]
   783   C0243083:associated disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0175648:mat [Medical Device]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "Demetrius M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Maraganore1, Paul Lockhart, Andrew Singleton, T.G. 

Phrase: "Maraganore1,"

Phrase: "Paul Lockhart,"

Phrase: "Andrew Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0481462:singleton [Finding]
   861   C1313913:Singleton [Family Group]

Phrase: "T.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.3: Lesnick2, Mariza de Andrade2, Andrew West, Rohan de Silva3, John Hardy+ and Dena Hernandez Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA, 1Department of Neurology and 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA and 3Reta Lila Weston Institute of Neurological Studies, 46 Cleveland Street, London W1T 4JF, UK Received May 9, 2001; 

Phrase: "Lesnick2,"

Phrase: "Mariza de Andrade2,"

Phrase: "Andrew West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705493:West [Spatial Concept]

Phrase: "Rohan de Silva3,"

Phrase: "John Hardy+"

Phrase: "and"

Phrase: "Dena Hernandez Department of Neuroscience,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Mayo Clinic,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "Jacksonville,"

Phrase: "FL 32224,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "1Department of Neurology"

Phrase: "and"

Phrase: "2Department of Health Sciences"

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: ","

Phrase: "Mayo Clinic,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "Rochester,"

Phrase: "MN 55905,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "3Reta Lila Weston Institute of Neurological Studies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021622:institute [Organization]
   748   C1272753:Institute [Idea or Concept]

Phrase: "46 Cleveland Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "London W1T 4JF,"

Phrase: "UK"

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "May 9,"

Phrase: "2001"

Phrase: ";"
Processing 00000000.tx.4: Revised and Accepted June 18, 2001.  

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted June 18,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2001."
Processing 00000000.tx.5: ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  We report haplotype analysis of the -synuclein gene in Parkinsons disease (PD), extending earlier reports of an association with a polymorphism within the gene promoter. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "haplotype analysis of the -synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in Parkinsons disease (PD),"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: "extending"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439792:Extending [Spatial Concept]
   966 E C0231448:Extend [Functional Concept]

Phrase: "earlier reports of an association"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0684224:Reports [Intellectual Product]
   760   C0700287:reports [Health Care Activity]
   726 E C3273238:Report [Intellectual Product]

Phrase: "with a polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "within the gene promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.6: This analysis showed significant differences in haplotypes between PD cases and controls. 

Phrase: "This analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant differences in haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "between PD cases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0030567:Parkinson Disease [Disease or Syndrome]
   734   C1521736:Parkinson's Disease [Functional Concept]
   734   C2681933:PARKINSON DISEASE [Gene or Genome]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.7: Our analyses demonstrate that genetic variability in the -synuclein gene is a risk factor for the development of PD. 

Phrase: "Our analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "demonstrate"

Phrase: "that genetic variability in the -synuclein gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2827666:Variability [Conceptual Entity]

Phrase: "is"

Phrase: "a risk factor for the development of PD."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   804   C0850664:risk factor (of) disease [Finding]
           disease risk factor
   764   C0035648:Risk factor [Quantitative Concept]
   762   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   762   C0679238:disease factor [Functional Concept]
   762   C0960756:factor A [Organic Chemical]
   762   C1281905:disease risk [Finding]
   742   C0035647:Risk [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.8: These genetic findings are analogous to the tau haplotype over-represented in progressive supranuclear palsy and further extend the similarity in the etiologies and pathogeneses of the synucleinopathies and tauopathies.  

Phrase: "These genetic findings"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   983   C0730319:Genetic finding [Laboratory or Test Result]
   955 E C0559563:Birth finding [Finding]
   941 E C0577203:Genital finding [Finding]
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "analogous to the tau haplotype"

Phrase: "over-represented in progressive supranuclear palsy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   790   C0270920:Supranuclear palsy [Disease or Syndrome]
   756   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   753   C0205136:Over [Spatial Concept]
   753   C0205329:Progressive [Functional Concept]
   753   C0522224:Palsy [Finding]
   719   C1882932:Represent [Activity]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "the similarity in the etiologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "pathogeneses of the synucleinopathies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0699748:Pathogeneses [Pathologic Function]
   737 E C0543483:pathogenesis [Functional Concept]

Phrase: "and"

Phrase: "tauopathies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]
Processing 00000000.tx.9: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Parkinsons disease (PD) consists of a clinical disorder characterized by a minimum of two of the three cardinal signs of bradykinesia, rigidity and tremor, with response to levodopa (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinsons disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: "(PD"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: ")"

Phrase: "consists of a clinical disorder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0012634:Disorder [Disease or Syndrome]
   760   C0205210:Clinical [Qualitative Concept]
   760   C0332529:CONSIST [Qualitative Concept]

Phrase: "characterized by a minimum of two of the three cardinal signs of bradykinesia,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   735   C0205448:Two [Quantitative Concept]
   735   C0205449:Three [Quantitative Concept]
   735   C0220912:signs [Functional Concept]
   735   C0220913:signs [Manufactured Object]
   735   C0233565:Bradykinesia [Sign or Symptom]
   735   C0311392:SIGNS [Finding]
   735   C0326926:Cardinal [Bird]
   735   C1524031:Minimum [Qualitative Concept]
   735   C1552614:minimum [Idea or Concept]
   735   C1880022:Characterized [Activity]
   735   C2700598:cardinal [Fungus]
   735   C2826545:MINIMUM [Quantitative Concept]
   702 E C1547188:Sign [Idea or Concept]

Phrase: "rigidity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0026837:Rigidity, NOS [Sign or Symptom]
  1000   C0700109:rigidity [Natural Phenomenon or Process]
   928 E C0231517:Rigid [Individual Behavior]
   928 E C1882952:RIGID [Phenomenon or Process]

Phrase: "and"

Phrase: "tremor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040822:Tremor [Sign or Symptom]
  1000   C1963252:Tremor [Finding]

Phrase: "with response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to levodopa"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0023570:Levodopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   944 E C0699991:Larodopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   944 E C0720022:Dopar [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.10: Pathologically it is defined by the presence of Lewy bodies, intracellular neuronal inclusions in the substantia nigra and at other sites in the brain (1). 

Phrase: "Pathologically"

Phrase: "it"

Phrase: "is"

Phrase: "defined by the presence of Lewy bodies,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0242821:bodies [Human]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1704788:Defined [Conceptual Entity]
   748   C1995017:Bodies [Cell Component]
   748   C3539106:Defined [Intellectual Product]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "intracellular neuronal inclusions in the substantia nigra"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1512693:Inclusion [Qualitative Concept]

Phrase: "and at other sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205145:Sites [Spatial Concept]
   770   C1515981:And [Idea or Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: These Lewy bodies are comprised at least in part of -synuclein (2) and mutations in -synuclein are the only, albeit rare, defined cause of this disorder (3). 

Phrase: "These Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "are"

Phrase: "comprised at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2700400:Comprise [Activity]

Phrase: "in part of -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1292711:Part of [Spatial Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "mutations in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "the only,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "albeit"

Phrase: "rare, defined cause of this disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: Most cases of PD occur sporadically and are of unknown etiology although, even in such sporadic cases, a genetic etiology may be important (4,5). 

Phrase: "Most cases of PD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "sporadically"

Phrase: "and"

Phrase: "are of unknown etiology"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0743626:unknown etiology [Finding]
   770   C0015127:aetiology [Functional Concept]
   770   C0439673:Unknown [Qualitative Concept]
   770   C1314792:Aetiology [Functional Concept]
   770   C1524003:Etiology [Conceptual Entity]
   770   C1551058:Are [Quantitative Concept]

Phrase: "although"

Phrase: ","

Phrase: "even in such sporadic cases,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205422:Sporadic [Temporal Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "a genetic etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015127:aetiology [Functional Concept]
   861   C1314792:Aetiology [Functional Concept]
   861   C1524003:Etiology [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "important"

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.13: This led us to investigate whether genetic variability in the -synuclein gene could predispose to PD. 

Phrase: "This led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "genetic variability in the -synuclein gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2827666:Variability [Conceptual Entity]

Phrase: "could"

Phrase: "predispose to PD."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.14: Genetic variability has been reported in the -synuclein promoter (6) and this has been suggested to show an association with PD (7,8) although this has been disputed (911).  

Phrase: "Genetic variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2827666:Variability [Conceptual Entity]
   789 E C0439828:Variable [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported in the -synuclein promoter"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(6"

Phrase: ")"

Phrase: "and"

Phrase: "this"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an association with PD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1511978:Disease Association [Temporal Concept]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "(7,"

Phrase: "8"

Phrase: ")"

Phrase: "although"

Phrase: "this"

Phrase: "has"

Phrase: "been"

Phrase: "disputed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0680226:dispute [Social Behavior]

Phrase: "(911"

Phrase: ")."
Processing 00000000.tx.15: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  We started our analysis by examining the promoter polymorphism (6). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "started"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272689:Started [Qualitative Concept]
   966 E C0439659:Start [Temporal Concept]

Phrase: "our analysis by examining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "the promoter polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.16: Our data is shown in Table 1 and suggests an association between the promoter polymorphism and disease (P = 0.005) (Table 1). 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "is"

Phrase: "shown in Table 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an association between the promoter polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(P = 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.17: However, we were concerned because of the variability in allele frequencies between populations and the disparity in association findings between studies (some positive, some negative), and because the polymorphism (referred to as Rep1) is a mixed sequence repeat (6). 

Phrase: "However,"

Phrase: "we"

Phrase: "were"

Phrase: "concerned because of the variability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C2827666:Variability [Conceptual Entity]
   726   C2699424:Concern [Idea or Concept]

Phrase: "in allele frequencies"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0017270:Frequencies, Allele [Quantitative Concept]
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "between populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "and"

Phrase: "the disparity in association findings"

Phrase: "between studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "("

Phrase: "some positive,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "some negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "because"

Phrase: "the polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "("

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "Rep1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413394:REP-1 [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "a mixed sequence repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.18: With this in mind we chose to sequence 50 individuals homozygous for the commonest 261 bp -synuclein promoter allele. 

Phrase: "With this in mind"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   861   C0229992:Mind, NOS [Mental Process]
   805 E C0229993:Psychic [Functional Concept]
   777 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   777 E C0042241:DIAPHRAGM [Medical Device]
   777 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   777 E C1705367:Diaphragm [Medical Device]
   761 E C0086045:mindfulness [Mental Process]
   761 E C3542996:Mindfulness [Mental Process]

Phrase: "we"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "50 individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "homozygous for the commonest 261 bp -synuclein promoter allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0019904:Homozygous [Organism Attribute]
Processing 00000000.tx.19: Sequence analysis demonstrated considerable variability in alleles of the same length. 

Phrase: "Sequence analysis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0936012:Analysis [Research Activity]
   861   C1519249:Sequence [Functional Concept]
   861   C1524024:analysis [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "considerable variability in alleles of the same length."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2827666:Variability [Conceptual Entity]
Processing 00000000.tx.20: The majority of variability lies within (TC)1011TT(TC)811(TA)79(CA)1011, the numerical subscript being indicative of the possible number of dinucleotide repeats within the four classes, although the total number of 39 repeats is consistent with allele size (Fig. 1). 

Phrase: "The majority of variability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "lies within"

Phrase: "(TC)1011TT"

Phrase: "(TC)811"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041405:TC [Geographic Area]
   861   C1824670:TC [Gene or Genome]
   861   C3272447:TC [Gene or Genome]

Phrase: "(TA)79"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "(CA)1011,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450317:1011 [Intellectual Product]

Phrase: "the numerical subscript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2825229:Subscript [Intellectual Product]

Phrase: "being"

Phrase: "indicative of the possible number of dinucleotide"

Phrase: "repeats within the four classes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205341:Repeat [Functional Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C0456387:Class [Intellectual Product]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]
   760   C1705943:Class [Classification]

Phrase: "although"

Phrase: "the total number of 39 repeats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0237753:*Number [Quantitative Concept]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "is"

Phrase: "consistent with allele size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.21: However, even within non-repetitive regions single nucleotide polymorphisms (SNPs) were common (data not shown). 

Phrase: "However,"

Phrase: "even within non-repetitive regions single nucleotide polymorphisms (SNPs)"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   800   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   770   C0086908:Repetitive Regions [Nucleotide Sequence]
   744   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0032529:polymorphisms [Genetic Function]
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0205171:Single [Quantitative Concept]
   744   C1518422:Non [Functional Concept]
   711   C0017446:Region [Geographic Area]
   711   C0205147:Region [Spatial Concept]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.22: This would confound conventional genotype association analysis, which relies on the assumption of allelic homogeneity and could lead to the masking of true allelic association by alleles of the same length. 

Phrase: "This"

Phrase: "would"

Phrase: "confound"

Phrase: "conventional genotype association analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "which"

Phrase: "relies on the assumption of allelic homogeneity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1881065:Homogeneity [Qualitative Concept]

Phrase: "and"

Phrase: "could"

Phrase: "lead to the masking of true allelic association"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   744   C0004083:Association [Mental Process]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0150112:masking [Functional Concept]
   744   C0205238:True [Qualitative Concept]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   711 E C0024861:Mask [Medical Device]
   711 E C1538279:MASK [Gene or Genome]
   711 E C1845191:MASK [Gene or Genome]

Phrase: "by alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "of the same length."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]
Processing 00000000.tx.23: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.24: -synuclein promoter polymorphism (Rep1)  View larger version (33K): [in this window] [in a new window]  Figure 1. 

Phrase: "-synuclein promoter polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Rep1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413394:REP-1 [Gene or Genome]

Phrase: ")"

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.25: Sequence analysis of homozygous -synuclein promoter alleles. 

Phrase: "Sequence analysis of homozygous -synuclein promoter alleles."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0936012:Analysis [Research Activity]
   748   C1519249:Sequence [Functional Concept]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.26: Shown are four variable dinucleotide repeat regions that contribute to the length of the commonest 261 bp Rep1 allele, sequenced from 50 individuals homozygous for that genotype. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "four variable dinucleotide repeat regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   771   C0017446:Region [Geographic Area]
   771   C0205147:Region [Spatial Concept]
   721 E C0205276:Regional [Spatial Concept]
   721 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "contribute to the length of the commonest 261 bp Rep1 allele,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   738   C0002085:Allele [Gene or Genome]
   738   C1413394:REP-1 [Gene or Genome]
   738   C1444754:Length [Quantitative Concept]
   738   C1706316:LENGTH [Research Activity]
   738   C1880177:Contribute [Activity]
   704   C0205214:Common [Quantitative Concept]
   704   C1522138:Common [Functional Concept]
   704   C3245511:common [Intellectual Product]

Phrase: "sequenced from 50 individuals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   737   C0004793:Sequence [Nucleotide Sequence]
   737   C0027361:Individual [Population Group]
   737   C0162326:Sequence [Nucleotide Sequence]
   737   C0162327:Sequence [Nucleotide Sequence]
   737   C0237401:Individual [Human]
   737   C1519249:Sequence [Functional Concept]

Phrase: "homozygous for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0019904:Homozygous [Organism Attribute]

Phrase: "that genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.27: Forty-eight percent of sequences (24/50 persons) were truly homozygous; 

Phrase: "Forty-eight percent of sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439165:Percent [Quantitative Concept]

Phrase: "(24/50 persons"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027361:Persons [Population Group]
   793 E C2347489:Person [Group]
   743 E C1519021:Personal [Organism Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "truly homozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygous [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.28: however, note that the underlying allelic architecture is different (shaded); 

Phrase: "however,"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the underlying allelic architecture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003737:Architecture [Occupation or Discipline]

Phrase: "is"

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "(shaded"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.29: 52% of sequences (26/50 persons) were heterozygous although the overall allele length is again 261 bp. 

Phrase: "52% of sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C0162326:Sequences [Nucleotide Sequence]
   756 E C0004793:Sequence [Nucleotide Sequence]
   756 E C0162327:Sequence [Nucleotide Sequence]
   756 E C1519249:Sequence [Functional Concept]
   706 E C1548958:Sequential [Idea or Concept]
   706 E C1705294:Sequential [Qualitative Concept]

Phrase: "(26/50 persons"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027361:Persons [Population Group]
   793 E C2347489:Person [Group]
   743 E C1519021:Personal [Organism Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "although"

Phrase: "the overall allele length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C1444754:Length [Quantitative Concept]
   827   C1706316:LENGTH [Research Activity]
   755 E C0205166:Long [Qualitative Concept]
   755 E C1522425:Longest [Qualitative Concept]
   755 E C1706317:Long [Qualitative Concept]

Phrase: "is"

Phrase: "again 261 bp."
Processing 00000000.tx.30: Similar sequence variability exists for other alleles (data not shown).  

Phrase: "Similar sequence variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C2827666:Variability [Conceptual Entity]
   755 E C0439828:Variable [Qualitative Concept]

Phrase: "exists for other alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0002085:Alleles [Gene or Genome]
   770   C2987476:Exist [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.31: Using PCR direct sequencing of the -synuclein promoter we were not able to distinguish specific alleles because of the complexity of the variability, in the absence of phase information. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR direct sequencing of the -synuclein promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1553778:Sequencing [Intellectual Product]
   748   C1561491:Sequencing [Functional Concept]

Phrase: "we"

Phrase: "were"

Phrase: "not able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1518422:Not [Functional Concept]

Phrase: "distinguish"

Phrase: "specific alleles because of the complexity of the variability,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Alleles [Gene or Genome]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of phase information."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]
Processing 00000000.tx.32: We therefore chose to try to dissect haplotypes by finding other genetic variability in the -synuclein gene and promoter (Materials and Methods). 

Phrase: "We therefore"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "try"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "dissect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissect [Functional Concept]

Phrase: "haplotypes by finding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018591:Haplotypes [Organism Attribute]

Phrase: "other genetic variability in the -synuclein gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2827666:Variability [Conceptual Entity]

Phrase: "and"

Phrase: "promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.33: Our search for additional polymorphic variability within the -synuclein gene and promoter (accession no. U46896) revealed 10 SNPs with which haplotypes might be estimated (Table 2). 

Phrase: "Our search for additional polymorphic variability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552603:search [Intellectual Product]
   753   C1706202:Search [Activity]

Phrase: "within the -synuclein gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510755:Accession [Intellectual Product]
  1000   C1706078:Accession [Activity]

Phrase: "no. U46896"

Phrase: ")"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "10 SNPs with which haplotypes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.34: Two from the promoter, 770 and 116, and two from the intron 4 region (IVS4) were chosen as they were all informative (heterozygosities of 50%), easily and unequivocally scored and did not appear to be in excessive linkage disequilibrium with each other, despite their physical proximity (Materials and Methods). 

Phrase: "Two from the promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205448:Two [Quantitative Concept]

Phrase: "770"

Phrase: "and"

Phrase: "116,"

Phrase: "and"

Phrase: "two from the intron 4 region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205448:Two [Quantitative Concept]

Phrase: "(IVS4"

Phrase: ")"

Phrase: "were"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "as"

Phrase: "they"

Phrase: "were"

Phrase: "all informative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986490:Informative [Qualitative Concept]

Phrase: "(heterozygosities of 50%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0019425:Heterozygosity [Organism Attribute]

Phrase: ")"

Phrase: ","

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "and"

Phrase: "unequivocally"

Phrase: "scored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:scored [Quantitative Concept]

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be in excessive linkage disequilibrium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C0442802:Excessive [Qualitative Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "with each other,"

Phrase: "despite their physical proximity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514583:Proximity [Spatial Concept]

Phrase: "(Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.35: We then tested each of these polymorphisms for association with disease in our population sample (Table 3). 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "each of these polymorphisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0032529:polymorphisms [Genetic Function]
   770   C1457900:Each [Quantitative Concept]
   737 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "for association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "in our population sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.36: The frequencies of alleles only differed significantly between PD cases and controls for the IVS4+78insG polymorphism (simulated P = 0.014). 

Phrase: "The frequencies of alleles only"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   781   C0017270:Frequencies, Allele [Quantitative Concept]
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "differed"

Phrase: "significantly between PD cases"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "controls for the IVS4+78insG polymorphism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0032529:Polymorphism [Genetic Function]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882417:Polymorphism [Qualitative Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(simulated P = 0.014"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0450302:0.014" [Quantitative Concept]
   812   C0284447:simulated [Biomedical or Dental Material]
   741 E C0679083:Simulation [Research Activity]

Phrase: ")."
Processing 00000000.tx.37: We then inferred haplotypes using the EM algorithm between the -synuclein promoter and the IVS4+78insG polymorphism and carried out an association study between these inferred haplotypes and disease (12,13). 

Phrase: "We then inferred haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the EM algorithm between the -synuclein promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0002045:algorithm [Intellectual Product]
   748   C1553907:algorithm [Laboratory Procedure]

Phrase: "and"

Phrase: "the IVS4+78insG polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "an association study between these inferred haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.38: To simplify this analysis and reduce the number of sparse cells, we grouped the two shortest and two longest categories of alleles for Rep1 in the -synuclein promoter (1 and 0 to 1, 1 to 2, and 2 and 3 to 3). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "simplify"

Phrase: "this analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "reduce"

Phrase: "the number of sparse cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "we"

Phrase: "grouped"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
  1000   C0439745:Grouped [Spatial Concept]
   966 E C0441833:Group [Idea or Concept]
   966 E C0687744:group [Population Group]
   966 E C1257890:Group [Population Group]
   966 E C1552516:Group [Health Care Related Organization]
   966 E C1705428:Group [Conceptual Entity]
   966 E C1705429:Group [Population Group]

Phrase: "the two shortest"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1806781:Shortest [Quantitative Concept]
   827 E C1282927:short [Qualitative Concept]
   827 E C2350002:Short [Quantitative Concept]

Phrase: "and"

Phrase: "two longest categories of alleles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0683312:Categories [Intellectual Product]
   726 E C1555713:category [Idea or Concept]

Phrase: "for Rep1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413394:REP-1 [Gene or Genome]

Phrase: "in the -synuclein promoter (1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "0 to 1,"

Phrase: "1 to 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0580272:1/2 [Intellectual Product]
   858   C1519043:1-2 [Research Activity]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3 to 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439086:<3 [Quantitative Concept]
   790   C2827736:3+ [Quantitative Concept]
   790   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.39: Since only six of the 48 possible five-locus haplotypes had estimated proportions >5% in this study (Table4), selecting subsets of important loci was difficult. 

Phrase: "Since only six of the 48 possible five-locus haplotypes"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0018591:Haplotypes [Organism Attribute]
   739   C0205171:Only [Quantitative Concept]
   739   C0205451:Five [Quantitative Concept]
   739   C0205452:Six [Quantitative Concept]
   739   C0332149:Possible [Qualitative Concept]
   739   C1705910:Possible [Qualitative Concept]
   739   C1708726:Locus [Gene or Genome]
   739   C1711239:Since [Temporal Concept]
   739   C1720467:Only [Intellectual Product]
   739   C2362652:Possible [Qualitative Concept]

Phrase: "had"

Phrase: "estimated proportions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1709707:Proportion [Quantitative Concept]
   777 E C0205351:Proportional [Qualitative Concept]

Phrase: ">5% in this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439084:>5 [Quantitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0728893:+5 [Quantitative Concept]
   770   C2603343:Study [Research Activity]

Phrase: "(Table4"

Phrase: ")"

Phrase: ","

Phrase: "selecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "subsets of important loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515021:Subset [Classification]

Phrase: "was"

Phrase: "difficult."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332218:Difficult [Qualitative Concept]
   928 E C1299586:Difficulty [Finding]
Processing 00000000.tx.40: However, the global likelihood ratio tests for three-locus configurations in Table 5 showed that combinations including Rep1 and the flanking loci had significantly different haplotype frequencies between PD cases and controls, whereas combinations not including those loci did not. 

Phrase: "However,"

Phrase: "the global likelihood ratio tests for three-locus configurations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C0150102:LIKELIHOOD RATIO [Quantitative Concept]
   742   C0022885:Tests [Laboratory Procedure]
   742   C0033204:Likelihood [Quantitative Concept]
   742   C0392366:Tests [Intellectual Product]
   742   C0456603:Ratio [Quantitative Concept]
   742   C1547037:Ratio [Intellectual Product]
   708 E C0039593:Test [Functional Concept]

Phrase: "in Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that combinations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0453882:Combinations [Manufactured Object]
   966 E C0205195:Combination [Qualitative Concept]
   966 E C1947911:Combination [Physical Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Rep1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413394:REP-1 [Gene or Genome]

Phrase: "and"

Phrase: "the flanking loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "had"

Phrase: "significantly different haplotype frequencies between PD cases"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   744   C0439603:Frequencies [Temporal Concept]
   711 E C0376249:frequency [Quantitative Concept]
   711 E C0871396:Frequency [Quantitative Concept]
   711 E C1561548:Frequency [Qualitative Concept]
   711 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "whereas"

Phrase: "combinations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0453882:Combinations [Manufactured Object]
   966 E C0205195:Combination [Qualitative Concept]
   966 E C1947911:Combination [Physical Object]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "did"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.41: This pattern also appeared in the two- and four-locus configurations (data not shown). 

Phrase: "This pattern also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "appeared in the two-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205448:Two [Quantitative Concept]
   737   C0700364:APPEAR [Qualitative Concept]

Phrase: "and"

Phrase: "four-locus configurations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449830:configurations [Spatial Concept]
   793 E C2827597:Configuration [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.42: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.43: Polymorphic variants identified within the -synuclein promoter and gene  View this table: [in this window] [in a new window]  Table 3. 

Phrase: "Polymorphic variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "identified within the -synuclein promoter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.44: -synuclein gene polymorphisms  View this table: [in this window] [in a new window]  Table 4. 

Phrase: "-synuclein gene polymorphisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0678951:gene polymorphisms [Genetic Function]
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.45: Pooled haplotype analyses for PD cases versus controls  View this table: [in this window] [in a new window]  Table 5. 

Phrase: "Pooled haplotype analyses for PD cases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "versus"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 5."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.46: Global Likelihood Ratio and P-values for three-locus haplotypes   DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Our findings may be considered analogous to the over-representation of H1 haplotypes about the tau locus in PSP. 

Phrase: "Global Likelihood Ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0150102:LIKELIHOOD RATIO [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "P-values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "for three-locus haplotypes   DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "analogous to the over-representation of H1 haplotypes"

Phrase: "about the tau locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "in PSP."
Processing 00000000.tx.47: In both PSP and PD, non-coding genetic variability contributes to the sporadic form of the disease entity (14 and this study). 

Phrase: "In both PSP"

Phrase: "and"

Phrase: "PD,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: "non-coding genetic variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C2827666:Variability [Conceptual Entity]
   741 E C0439828:Variable [Qualitative Concept]

Phrase: "contributes to the sporadic form of the disease entity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0012634:Disease [Disease or Syndrome]
   742   C0205422:Sporadic [Temporal Concept]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]
   742   C1551338:Entity [Entity]
   742   C1880177:Contribute [Activity]

Phrase: "(14"

Phrase: "and"

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: ")."
Processing 00000000.tx.48: The precise mechanism by which non-coding variability in the -synuclein gene predisposes to disease is not clear: however, recent analysis of the -synuclein promoter suggests that the region of the promoter in which the polymorphism is found participates in the control of gene expression (15). 

Phrase: "The precise mechanism by which non-coding variability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "in the -synuclein gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "predisposes to disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0012634:Disease [Disease or Syndrome]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ":"

Phrase: "however,"

Phrase: "recent analysis of the -synuclein promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the region of the promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "in which"

Phrase: "the polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "participates in the control of gene expression"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0017262:Gene Expression [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.49: Thus, it is possible that this polymorphism is itself biologically relevant, although the possibility that some other control element may be in linkage disequilibrium cannot be discounted.  

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "this polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "itself biologically relevant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]

Phrase: "although"

Phrase: "the possibility"

Phrase: "that"

Phrase: "some other control element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "may"

Phrase: "be in linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C2987476:Be [Conceptual Entity]

Phrase: "cannot"

Phrase: "be"

Phrase: "discounted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555671:discount [Intellectual Product]
Processing 00000000.tx.50: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Subjects The study from which these cases and controls were derived has been previously described (16). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "The study from which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "these cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.51: After informed consent, blood samples were drawn for DNA extraction from 319 cases and 196 controls. 

Phrase: "After informed consent,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0021430:Informed Consent [Regulation or Law]
   861   C1511481:Consent [Functional Concept]
   861   C1522154:Informed [Qualitative Concept]
   861   C1554192:consent [Idea or Concept]
   827 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827 E C0700287:inform [Health Care Activity]
   827 E C1552002:inform [Idea or Concept]

Phrase: "blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "drawn for DNA extraction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0185115:Extraction [Therapeutic or Preventive Procedure]
   770   C0684295:extraction [Laboratory Procedure]
   737   C0013113:Draw [Intellectual Product]

Phrase: "from 319 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "196 controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.52: Cases and controls are Caucasian residents of Minnesota or the surrounding four states (Wisconsin, Iowa, South Dakota and North Dakota) with parents of European extraction. 

Phrase: "Cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "are"

Phrase: "Caucasian residents of Minnesota"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1320928:Resident [Professional or Occupational Group]
   737   C1549439:Resident [Intellectual Product]
   737   C2347958:Resident [Human]

Phrase: "or"

Phrase: "the surrounding four states"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1301808:states [Geographic Area]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]

Phrase: "(Wisconsin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:Wisconsin [Geographic Area]

Phrase: "Iowa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022037:Iowa [Geographic Area]
  1000   C1555231:Iowa [Population Group]

Phrase: "South Dakota"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0037717:South Dakota [Geographic Area]
   861   C0445474:Dakota [Intellectual Product]
   861   C0574595:Dakota [Language]
   861   C1551611:Dakota [Population Group]
   861   C1710133:South [Spatial Concept]
   789 E C1698645:Dakotan [Language]

Phrase: "and"

Phrase: "North Dakota"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0028408:North Dakota [Geographic Area]
   861   C0445474:Dakota [Intellectual Product]
   861   C0574595:Dakota [Language]
   861   C1551611:Dakota [Population Group]
   861   C1709269:North [Spatial Concept]
   789 E C1698645:Dakotan [Language]

Phrase: ")"

Phrase: "with parents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0030551:Parents [Family Group]
   966 E C2699423:Parent [Conceptual Entity]

Phrase: "of European extraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.53: The median age at onset of cases was 64 years (range 3191 years) and the median age at sampling of controls was 72 years (range 3794 years). 

Phrase: "The median age at onset of cases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   748   C0001779:Age [Organism Attribute]
   748   C0332162:Onset [Qualitative Concept]

Phrase: "was"

Phrase: "64 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(range 3191 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the median age at sampling of controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "72 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(range 3794 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.54: Molecular analysis of the promoter polymorphism Xia et al. 

Phrase: "Molecular analysis of the promoter polymorphism Xia et al."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1513380:Molecular Analysis [Molecular Biology Research Technique]
   762   C0796451:polymorphism analysis [Diagnostic Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
Processing 00000000.tx.55: (6) first reported a polymorphic dinucleotide repeat polymorphism in the -synuclein gene. 

Phrase: "(6"

Phrase: ")"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "a polymorphic dinucleotide repeat polymorphism in the -synuclein gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0678951:gene polymorphism [Genetic Function]
   742   C0032529:Polymorphism [Genetic Function]
   742   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.56: However, when we analyzed this polymorphism by sequencing, we noted that it was a mixed repeat and that alleles of similar sizes had different sequences. 

Phrase: "However,"

Phrase: "when"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "this polymorphism by sequencing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032529:Polymorphism [Genetic Function]
   770   C1882417:Polymorphism [Qualitative Concept]

Phrase: "we"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "it"

Phrase: "was"

Phrase: "a mixed repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205341:Repeat [Functional Concept]
   861   C1547730:Repeat [Temporal Concept]
   861   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "that alleles of similar sizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Alleles [Gene or Genome]

Phrase: "had"

Phrase: "different sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.57: Forward and fluorescently tagged reverse primers were designed to the -synuclein promoter locus (accession no. U46895), Fam5'-CCT GGC ATA TTT GAT TGC AA-3' and 5'-GAC TGG CCC AAG ATT AAC CA-3'. 

Phrase: "Forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "and"

Phrase: "fluorescently tagged reverse primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed to the -synuclein promoter locus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1708726:Locus [Gene or Genome]
   719   C1707689:Design [Activity]
   719   C2983265:DESIGN [Intellectual Product]

Phrase: "(accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510755:Accession [Intellectual Product]
  1000   C1706078:Accession [Activity]

Phrase: "no. U46895"

Phrase: ")"

Phrase: ","

Phrase: "Fam5'-CCT GGC ATA TTT GAT TGC AA-3'"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   807   C0444860:Aa 3 [Intellectual Product]
   791   C0061145:GAT [Amino Acid, Peptide, or Protein]
   791   C0266539:CCT [Congenital Abnormality,Disease or Syndrome]
   791   C1235746:Aa [Plant]
   791   C1415027:Ggc [Gene or Genome]
   791   C1420714:TGC [Gene or Genome]
   791   C1422172:GAT [Gene or Genome]
   791   C1882141:aa [Qualitative Concept]

Phrase: "and"

Phrase: "5'-GAC TGG CCC AAG ATT AAC CA-3'."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   791   C0439084:>5 [Quantitative Concept]
   791   C0728893:+5 [Quantitative Concept]
   791   C0796552:AAG [Antibiotic,Organic Chemical]
   791   C1417239:AAG [Gene or Genome]
   791   C2986643:AAG [Gene or Genome]
Processing 00000000.tx.58: Defining other variability with the -synuclein gene Single nucleotide variants within the -synuclein promoter (accession no. U46896) were identified by sequencing overlapping PCR products derived from amplification of an equimolar pool of five samples, the products being sequenced in both directions using dRhodamine terminators. 

Phrase: "Defining"

Phrase: "other variability with the -synuclein gene Single nucleotide variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C2827666:Variability [Conceptual Entity]
   726   C3258294:Variable nucleotide [Finding]

Phrase: "within the -synuclein promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510755:Accession [Intellectual Product]
  1000   C1706078:Accession [Activity]

Phrase: "no. U46896"

Phrase: ")"

Phrase: "were"

Phrase: "identified by sequencing overlapping PCR products"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0185027:Overlapping [Therapeutic or Preventive Procedure]
   753   C0205396:Identified [Qualitative Concept]
   753   C0677874:pCR [Finding]
   753   C1514468:Products [Entity]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1553778:Sequencing [Intellectual Product]
   753   C1561491:Sequencing [Functional Concept]
   753   C1948020:Overlapping [Conceptual Entity]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "derived from amplification of an equimolar pool of five samples,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   741   C1509144:Sample pool [Clinical Attribute]
           pool
   739   C0205451:Five [Quantitative Concept]
   739   C0337051:Pool [Geographic Area]
   739   C1441547:Derived [Qualitative Concept]
   739   C1517480:Amplification [Molecular Biology Research Technique]
   739   C1521871:Amplification [Phenomenon or Process]
   739   C1705759:Amplification [Cell or Molecular Dysfunction]
   739   C2349200:Pool [Functional Concept]
   739   C3245521:derived [Idea or Concept]
   706   C0370003:Sample [Substance]
   706   C2347026:Sample [Conceptual Entity]

Phrase: "the products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "being"

Phrase: "sequenced in both directions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0439755:Directions [Spatial Concept]
   737   C0004793:Sequence [Nucleotide Sequence]
   737   C0162326:Sequence [Nucleotide Sequence]
   737   C0162327:Sequence [Nucleotide Sequence]
   737 E C0449738:Direction [Spatial Concept]
   737   C1519249:Sequence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "dRhodamine terminators."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0851166:TERMINATOR [Pharmacologic Substance]
   827   C1705818:Terminator [Manufactured Object]
   827   C3205287:Terminator [Pharmacologic Substance]
Processing 00000000.tx.59: Fluorescent genotyping and sequencing were performed on an ABI377, the former analyzed using Genescan and Genotyper software, chromatograms aligned and base calls assessed using PolyPhredPhrap (17). 

Phrase: "Fluorescent genotyping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285573:Genotyping [Laboratory Procedure]

Phrase: "and"

Phrase: "sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "were"

Phrase: "performed on an ABI377,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the former analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Genescan"

Phrase: "and"

Phrase: "Genotyper software,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "chromatograms"

Phrase: "aligned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706765:Aligned [Quantitative Concept]
   966 E C2369992:Align [Pharmacologic Substance]

Phrase: "and"

Phrase: "base calls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0679006:Call [Mental Process]
   827   C1947967:Call [Functional Concept]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PolyPhredPhrap"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.60: This software is sufficiently sensitive to call a base mismatch in 1/5 sequences (less common variants would not have been informative for further genotyping analysis). 

Phrase: "This software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "is"

Phrase: "sufficiently sensitive to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0332324:Sensitive to [Functional Concept]
           Sensitive
   827   C1550474:sensitive [Idea or Concept]

Phrase: "call"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679006:Call [Mental Process]
  1000   C1947967:Call [Functional Concept]

Phrase: "a base mismatch in 1/5 sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1881865:Mismatch [Qualitative Concept]

Phrase: "(less common variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "informative for further genotyping analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986490:Informative [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.61: Single base variants identified were confirmed by restriction digest, using an appropriate enzyme (New England Biolabs). 

Phrase: "Single base variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "were"

Phrase: "confirmed by restriction"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0443288:Restriction [Functional Concept]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "digest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digest [Physiologic Function]

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an appropriate enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(New England Biolabs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: ")."
Processing 00000000.tx.62: Initially, a subset of 20 control samples was typed to assess heterozygosity and whether neighboring markers were in disequilibrium (whether samples homo- or heterozygous for one marker were invariably homo- or heterozygous for an adjacent marker). 

Phrase: "Initially,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "a subset of 20 control samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515021:Subset [Classification]

Phrase: "was"

Phrase: "typed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332307:Type [Qualitative Concept]
   966   C1547052:*Type [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "heterozygosity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygosity [Organism Attribute]

Phrase: "and"

Phrase: "whether"

Phrase: "neighboring markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "were in disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0281825:Disequilibrium [Finding]
   790   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "("

Phrase: "whether"

Phrase: "samples homo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "or"

Phrase: "heterozygous for one marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019425:Heterozygous [Organism Attribute]

Phrase: "were"

Phrase: "invariably homo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "or"

Phrase: "heterozygous for an adjacent marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019425:Heterozygous [Organism Attribute]

Phrase: ")."
Processing 00000000.tx.63: Larger sized alleles were denoted 1, smaller alleles, 2. 

Phrase: "Larger sized alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "were"

Phrase: "denoted"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "smaller alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.64: Promoter variants 770 and 116 were assayed using PCR primers 5'-AAG AGT GCT CGT GAC CCT AAAC-3', 5'-TTG AAG GCA AGG CGT GAG-3', and 5'-CCG GTA GGC TAA ATC ACGC-3', 5'-CCA CCA AGG GCA GAG CTA TC-3', respectively, products digested with either CfoI or Cac81, according to the manufacturers conditions. 

Phrase: "Promoter variants 770"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205419:variants [Qualitative Concept]

Phrase: "and"

Phrase: "116"

Phrase: "were"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR primers 5'-AAG AGT GCT CGT GAC CCT AAAC-3',"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   788   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   788   C0266539:CCT [Congenital Abnormality,Disease or Syndrome]
   788   C0677874:pCR [Finding]
   788   C0796552:AAG [Antibiotic,Organic Chemical]
   788   C1417239:AAG [Gene or Genome]
   788   C2986643:AAG [Gene or Genome]
   788   C3538813:GCT [Gene or Genome]
   755   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5'-TTG AAG GCA AGG CGT GAG-3',"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0439084:>5 [Quantitative Concept]
   793   C0728893:+5 [Quantitative Concept]
   793   C0796552:AAG [Antibiotic,Organic Chemical]
   793   C1417239:AAG [Gene or Genome]
   793   C2986643:AAG [Gene or Genome]

Phrase: "and"

Phrase: "5'-CCG GTA GGC TAA ATC ACGC-3',"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0039872:TAA [Hazardous or Poisonous Substance,Organic Chemical]
   793   C0162872:TAA [Disease or Syndrome]
   793   C0439084:>5 [Quantitative Concept]
   793   C0728893:+5 [Quantitative Concept]
   793   C1415027:Ggc [Gene or Genome]
   793   C1516476:CCG [Health Care Related Organization]
   793   C2697657:GTA [Gene or Genome]

Phrase: "5'-CCA CCA AGG GCA GAG CTA TC-3',"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   791   C0041405:TC [Geographic Area]
   791   C0220668:CCA [Congenital Abnormality]
   791   C0439084:>5 [Quantitative Concept]
   791   C0728893:+5 [Quantitative Concept]
   791   C1824670:TC [Gene or Genome]
   791   C3272447:TC [Gene or Genome]
   791   C3540513:CTA [Gene or Genome]

Phrase: "respectively,"

Phrase: "products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "digested with either CfoI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0868946:digested [Physiologic Function]

Phrase: "or"

Phrase: "Cac81,"

Phrase: "according to the manufacturers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0947322:Manufacturer [Intellectual Product]
   966   C1705426:Manufacturer [Population Group]

Phrase: "conditions."
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]
Processing 00000000.tx.65: The intron 4 (accession no. U46899) IVS4+66AG polymorphism was assayed using primers NACP 4F 5'-TCG ATG GCT AGT GGA AGT GG-3' and NACP 4R 5'-CCC ACA GTA AGT ATC TTG CTCC-3', followed by digestion with HaeIII. 

Phrase: "The intron 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510755:Accession [Intellectual Product]
  1000   C1706078:Accession [Activity]

Phrase: "no. U46899"

Phrase: ")"

Phrase: "IVS4+66AG polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers NACP 4F 5'-TCG ATG GCT AGT GGA AGT GG-3'"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   787   C0018370:GG [Geographic Area]
   787   C0285890:NACP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0450379:4f [Intellectual Product]
   787   C1420276:NACP [Gene or Genome]
   787   C2983377:NACP [Gene or Genome]
   787   C3538813:GCT [Gene or Genome]
   754   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "NACP 4R 5'-CCC ACA GTA AGT ATC TTG CTCC-3',"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   788   C0149561:ACA [Body Part, Organ, or Organ Component]
   788   C0285890:NACP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C1420276:NACP [Gene or Genome]
   788   C2697657:GTA [Gene or Genome]
   788   C2983377:NACP [Gene or Genome]

Phrase: "followed by digestion"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0012238:Digestion [Organism Function]
   790   C2349986:Digestion [Research Activity]
   756 E C1719822:Follow [Intellectual Product]
   734 E C0443277:Peptic [Functional Concept]

Phrase: "with HaeIII."
Processing 00000000.tx.66: The IVS4+78insG polymorphism was additionally confirmed by sequencing this region in 10 control cases. 

Phrase: "The IVS4+78insG polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "additionally"

Phrase: "confirmed by sequencing"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "this region in 10 control cases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
Processing 00000000.tx.67: A restriction digest assay was designed using the mismatch primers NACP 4F 5'-TCG ATG GCT AGT GGA AGT GG-3' and NACP 4R mismatch 5'-CCC ACA GTA AGT ATC TTG CTGC-3' and digesting with Cac81. 

Phrase: "A restriction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:Restriction [Functional Concept]

Phrase: "digest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digest [Physiologic Function]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the mismatch primers NACP 4F 5'-TCG ATG GCT AGT GGA AGT GG-3'"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   786   C0018370:GG [Geographic Area]
   786   C0285890:NACP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C0450379:4f [Intellectual Product]
   786   C1420276:NACP [Gene or Genome]
   786   C1881865:Mismatch [Qualitative Concept]
   786   C2983377:NACP [Gene or Genome]
   786   C3538813:GCT [Gene or Genome]
   753   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "NACP 4R mismatch 5'-CCC ACA GTA AGT ATC TTG CTGC-3'"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   787   C0149561:ACA [Body Part, Organ, or Organ Component]
   787   C0285890:NACP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C1420276:NACP [Gene or Genome]
   787   C1881865:Mismatch [Qualitative Concept]
   787   C2697657:GTA [Gene or Genome]
   787   C2983377:NACP [Gene or Genome]

Phrase: "and"

Phrase: "digesting with Cac81."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digesting [Physiologic Function]
Processing 00000000.tx.68: Statistical analysis Model-free statistics were used to test for allelic association between PD cases and polymorphisms. 

Phrase: "Statistical analysis Model-free statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0038215:Statistics [Occupation or Discipline]
   804   C0600673:Statistics [Intellectual Product]
   771 E C2348149:Statistic [Quantitative Concept]
   771 E C2828391:Statistic [Quantitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for allelic association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0017381:Allelism Test [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0004083:Association [Mental Process]
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "between PD cases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0030567:Parkinson Disease [Disease or Syndrome]
   734   C1521736:Parkinson's Disease [Functional Concept]
   734   C2681933:PARKINSON DISEASE [Gene or Genome]

Phrase: "and"

Phrase: "polymorphisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.69: To overcome the problem of inaccuracy of the asymptotic 2 distribution due to sparse genotypes in contingency tables, permutation tests for allelic association and estimation of haplotypes were performed (12,13). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "the problem of inaccuracy of the asymptotic 2 distribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0033213:Problem [Finding]

Phrase: "due to sparse genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "in contingency tables,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0039224:tables [Manufactured Object]
   861   C1701901:Contingency [Qualitative Concept]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "permutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882348:Permutation [Qualitative Concept]

Phrase: "tests for allelic association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0017381:Allelism Test [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0004083:Association [Mental Process]
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:Tests [Intellectual Product]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "estimation of haplotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0680844:estimation [Mental Process]
   790   C0681916:Estimation [Quantitative Concept]
   790   C0750572:Estimation [Quantitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.70: All reported P-values for haplotype analysis were simulated using Monte Carlo methods. 

Phrase: "All reported P-values for haplotype analysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0042295:Values [Qualitative Concept]
   745   C1709380:P-Value [Quantitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "simulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulated [Biomedical or Dental Material]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Monte Carlo methods."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   983   C0026507:Monte Carlo Method [Quantitative Concept]
           Monte Carlo
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.71: All analyses were performed using SAS and S-Plus software packages.  

Phrase: "All analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SAS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0605290:SAS [Organic Chemical]
  1000   C1426104:SAS [Gene or Genome]
  1000   C1823519:SAS [Gene or Genome]

Phrase: "and S-"

Phrase: "Plus software packages."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0013194:Package [Medical Device]
   793   C2700580:Package [Manufactured Object]
Processing 00000000.tx.72: ACKNOWLEDGEMENTS  We are indebted to the patients and their spouses who made this work feasible. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "indebted to the patients"

Phrase: "and"

Phrase: "their spouses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162409:Spouses [Family Group]

Phrase: "who"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "this work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "feasible."
Processing 00000000.tx.73: We thank Daniel J. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Daniel J."
Processing 00000000.tx.74: Schaid, PhD and Shannon K. 

Phrase: "Schaid,"

Phrase: "PhD"

Phrase: "and"

Phrase: "Shannon K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.75: McDonnell, MS for additional statistical assistance. 

Phrase: "McDonnell,"

Phrase: "MS for additional statistical assistance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   760   C2349943:Ms. [Conceptual Entity]
   760   C3539704:MS [Gene or Genome]
Processing 00000000.tx.76: M.F. and A.S. were supported in part by ADRC grant 1JA 1A3171; 

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "A.S."

Phrase: "were"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by ADRC grant 1JA 1A3171"

Phrase: ";"
Processing 00000000.tx.77: D.M.M. 

Phrase: "D."

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.78: M.d.A. and T.G.L. by NIH grants NS33978, ES10751 and the Mayo Foundation; 

Phrase: "M.d.A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1512018:M.D. [Intellectual Product]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "T.G.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0439294:g l [Quantitative Concept]

Phrase: "by NIH grants NS33978,"

Phrase: "ES10751"

Phrase: "and"

Phrase: "the Mayo Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.79: and M.F., D.M.M. and J.H. by an NIH/NINDS Udall Center grant.  

Phrase: "and"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "D."

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "by an NIH/NINDS Udall Center grant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0018173:Grant [Quantitative Concept]
   804   C1548284:Grant [Idea or Concept]
Processing 00000000.tx.80: FOOTNOTES  + To whom correspondence should be addressed. 

Phrase: "FOOTNOTES  +"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.81: Tel: +1 904 953 7356; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 904 953 7356"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.82: Fax: +1 904 953 7370; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 904 953 7370"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.83: Email: hardy@mayo.edu  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  1 Gelb, D.J., Oliver, E. and Gilman, S. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "hardy@mayo.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Gelb,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0165519:GELB [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1334523:GELB [Gene or Genome]
   861   C1708832:GELB [Gene or Genome]

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Oliver,"

Phrase: "E."

Phrase: "and"

Phrase: "Gilman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.84: (1999) Diagnostic criteria for Parkinson disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Diagnostic criteria for Parkinson disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0679228:diagnostic criteria [Intellectual Product]
   760   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.85: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.86: Neurol., 56, 3339.[Abstract/Free FullText] 2 Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M. and Goedert, M. 

Phrase: "Neurol.,"

Phrase: "56,"

Phrase: "3339."

Phrase: "[Abstract/Free FullText"

Phrase: "] 2 Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hasegawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.87: (1998) -synuclein in filamentous inclusions of Lewy bodies from Parkinsons disease and dementia with lewy bodies. 

Phrase: "(1998"

Phrase: ") -"

Phrase: "synuclein in filamentous inclusions of Lewy bodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from Parkinsons disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "dementia with lewy bodies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.88: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.89: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.90: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.91: USA, 95, 64696473.[Abstract/Free FullText] 3 Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "95,"

Phrase: "64696473."

Phrase: "[Abstract/Free FullText"

Phrase: "] 3 Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R. et al."
Processing 00000000.tx.92: (1997) Mutation in the -synuclein gene identified in families with Parkinsons disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutation in the -synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0596611:Gene Mutation [Genetic Function]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinsons disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.93: Science, 276, 20452047.[Abstract/Free FullText] 4 Sveinbjornsdottir, S., Hicks, A.A., Jonsson, T., Petursson, H., Guomundsson, G., Frigge, M.L., Kong, A., Gulcher, J.R. and Stefansson,K. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "276,"

Phrase: "20452047."

Phrase: "[Abstract/Free FullText"

Phrase: "] 4 Sveinbjornsdottir,"

Phrase: "S."

Phrase: ","

Phrase: "Hicks,"

Phrase: "A."

Phrase: "A.,"

Phrase: "Jonsson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Petursson,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guomundsson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Frigge,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kong,"

Phrase: "A.,"

Phrase: "Gulcher,"

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Stefansson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.94: (2000) Familial aggregation of Parkinsons disease in Iceland. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Familial aggregation of Parkinsons disease"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "in Iceland."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020750:Iceland [Geographic Area]
   928 E C0020751:Icelandic [Language]
Processing 00000000.tx.95: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.96: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.97: J. 

Phrase: "J."
Processing 00000000.tx.98: Med., 343, 17651770.[Abstract/Free FullText] 5 Farrer, M., Gwinn-Hardy, K., Hutton, M. and Hardy, J. 

Phrase: "Med.,"

Phrase: "343,"

Phrase: "17651770."

Phrase: "[Abstract/Free FullText"

Phrase: "] 5 Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.99: (1999) The genetics of disorders with synuclein pathology and parkinsonism. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The genetics of disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017398:Genetics [Biomedical Occupation or Discipline]
   770   C0017399:genetics [Biologic Function]

Phrase: "with synuclein pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "parkinsonism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.100: Hum.Mol. 

Phrase: "Hum.Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   777 E C0026367:Molar [Body Part, Organ, or Organ Component]
   761 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.101: Genet., 8, 19011905.[Abstract/Free FullText] 6 Xia, Y., de Silva, R.H.A., Rosi, B.L., Yamaoka, L.H., Rimmler, J.B., Pericak-Vance, M.A., Roses, A.D., Chen, X., Masliah, E., DeTeresa, R. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "19011905."

Phrase: "[Abstract/Free FullText"

Phrase: "] 6 Xia,"

Phrase: "Y.,"

Phrase: "de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "R.H."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Rosi,"

Phrase: "B.L., Yamaoka,"

Phrase: "L.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Rimmler,"

Phrase: "J.B.,"

Phrase: "Pericak-Vance,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.,"

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "DeTeresa,"

Phrase: "R. etal."
Processing 00000000.tx.102: (1996) Genetic studies in Alzheimers disease with an NACP/-synuclein polymorphism. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Genetic studies in Alzheimers disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C2827447:Genetic Study [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "with an NACP/-synuclein polymorphism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.103: Ann. 

Phrase: "Ann."
Processing 00000000.tx.104: Neurol., 40, 207215.[ISI][Medline] 7 Kruger, R., Vieira-Saecker, A.M., Kuhn, W., Berg, D., Muller, T., Kuhnl,N., Fuchs, G.A., Storch, A., Hungs, M., Woitalla, D. et al. 

Phrase: "Neurol.,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "207215."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 7 Kruger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vieira-Saecker,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Berg,"

Phrase: "D."

Phrase: ","

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kuhnl,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Fuchs,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "Storch,"

Phrase: "A.,"

Phrase: "Hungs,"

Phrase: "M."

Phrase: ","

Phrase: "Woitalla,"

Phrase: "D. et al."
Processing 00000000.tx.105: (1999) Increased susceptibility to sporadic Parkinsons disease by a certain combined -synuclein/apolipoprotein E genotype. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Increased susceptibility to sporadic Parkinsons disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "by a certain combined -synuclein/apolipoprotein E genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.106: Ann. 

Phrase: "Ann."
Processing 00000000.tx.107: Neurol., 45, 611617.[ISI][Medline] 8 Tan, E.K., Matsuura, T., Nagamitsu, S., Khajavi, M., Jankovic, J. and Ashizawa, T. 

Phrase: "Neurol.,"

Phrase: "45,"

Phrase: "611617."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 8 Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302595:tan [Individual Behavior]
   861   C1537110:Tan [Clinical Attribute]
   861   C3275241:Tan [Qualitative Concept]

Phrase: "E.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Matsuura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nagamitsu,"

Phrase: "S."

Phrase: ","

Phrase: "Khajavi,"

Phrase: "M."

Phrase: ","

Phrase: "Jankovic,"

Phrase: "J."

Phrase: "and"

Phrase: "Ashizawa,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.108: (2000) Polymorphism of NACP-Rep1 in Parkinsons disease: an etiologic link with essential tremor? 

Phrase: "(2000"

Phrase: ")"

Phrase: "Polymorphism of NACP-Rep1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032529:Polymorphism [Genetic Function]
   770   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in Parkinsons disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: ":"

Phrase: "an etiologic link with essential tremor?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]
Processing 00000000.tx.109: Neurology, 54, 11951198.[Abstract/Free FullText] 9 Parsian, A., Racette, B., Zhang, Z.H., Chakraverty, S., Rundle, M., Goate, A. and Perlmutter, J.S. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "54,"

Phrase: "11951198."

Phrase: "[Abstract/Free FullText"

Phrase: "] 9 Parsian,"

Phrase: "A.,"

Phrase: "Racette,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "Z.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Chakraverty,"

Phrase: "S."

Phrase: ","

Phrase: "Rundle,"

Phrase: "M."

Phrase: ","

Phrase: "Goate,"

Phrase: "A."

Phrase: "and"

Phrase: "Perlmutter,"

Phrase: "J.S."
Processing 00000000.tx.110: (1998) Mutation, sequence analysis, and association studies of -synuclein in Parkinsons disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "sequence analysis,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0936012:Analysis [Research Activity]
   861   C1519249:Sequence [Functional Concept]
   861   C1524024:analysis [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "of -synuclein in Parkinsons disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.111: Neurology, 51, 17571759.[Abstract] 10 Izumi, Y., Morino, H., Oda, M., Maruyama, H., Udaka, F., Kameyama, M., Nakamura, S. and Kawakami, H. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "51,"

Phrase: "17571759."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 10 Izumi,"

Phrase: "Y.,"

Phrase: "Morino,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "M."

Phrase: ","

Phrase: "Maruyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Udaka,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kameyama,"

Phrase: "M."

Phrase: ","

Phrase: "Nakamura,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kawakami,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.112: (2001) Genetic studies in Parkinsons disease with an -synuclein/NACP gene polymorphism in Japan. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Genetic studies in Parkinsons disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C2827447:Genetic Study [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "with an -synuclein/NACP gene polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678951:gene polymorphism [Genetic Function]
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.113: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.114: Lett., 300, 125127.[ISI][Medline] 11 Khan, N., Graham, E., Dixon, P., Morris, C., Mander, A., Clayton, D., Vaughan, J., Quinn, N., Lees, A., Daniel, S. et al. 

Phrase: "Lett.,"

Phrase: "300,"

Phrase: "125127."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 11 Khan,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Graham,"

Phrase: "E.,"

Phrase: "Dixon,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Morris,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mander,"

Phrase: "A.,"

Phrase: "Clayton,"

Phrase: "D."

Phrase: ","

Phrase: "Vaughan,"

Phrase: "J.,"

Phrase: "Quinn,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lees,"

Phrase: "A.,"

Phrase: "Daniel,"

Phrase: "S. et al."
Processing 00000000.tx.115: (2001) Parkinsons disease is not associated with the combined -synuclein/apolipoprotein E susceptibility genotype. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Parkinsons disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with the combined -synuclein/apolipoprotein E susceptibility genotype."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   764   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0012655:Susceptibility [Clinical Attribute]
   742   C0017431:Genotype [Organism Attribute]
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205195:Combined [Qualitative Concept]
   742   C0220898:Susceptibility [Organism Attribute]
   742   C1264642:Susceptibility [Functional Concept]
   742   C1547045:*Susceptibility [Quantitative Concept]
   708 E C0336789:Combine [Manufactured Object]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.116: Ann. 

Phrase: "Ann."
Processing 00000000.tx.117: Neurol., 49, 665668.[ISI][Medline] 12 Xie, X. and Ott, J. 

Phrase: "Neurol.,"

Phrase: "49,"

Phrase: "665668."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 12 Xie,"

Phrase: "X."

Phrase: "and"

Phrase: "Ott,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423088:OTT [Gene or Genome]
  1000   C3273338:OTT [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.118: (1993) Testing linkage disequilibrium between a disease gene and marker loci. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Testing linkage disequilibrium between a disease gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0023746:Linkage Disequilibrium [Quantitative Concept]
   748   C0023745:linkage [Molecular Function]
   748   C0281825:Disequilibrium [Finding]
   748   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "marker loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.119: Am. 

Phrase: "Am."
Processing 00000000.tx.120: J. 

Phrase: "J."
Processing 00000000.tx.121: Hum. 

Phrase: "Hum."
Processing 00000000.tx.122: Genet., 53, 1107.[ISI][Medline] 13 Zhao, J.H., Curtis, D. and Sham, P.C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "53,"

Phrase: "1107."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 13 Zhao,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Curtis,"

Phrase: "D."

Phrase: "and"

Phrase: "Sham,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0068899:S-HAM [Therapeutic or Preventive Procedure]
  1000   C0073980:SHAM [Organic Chemical,Pharmacologic Substance]

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.123: (2000) Model-free analysis and permutation tests for allelic associations. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Model-free analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "permutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882348:Permutation [Qualitative Concept]

Phrase: "tests for allelic associations."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   783   C0017381:Allelism Test [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0004083:Associations [Mental Process]
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:Tests [Intellectual Product]
   737 E C0439849:Association [Qualitative Concept]
   737 E C0596306:Association [Phenomenon or Process]
   737 E C0699792:association [Social Behavior]
Processing 00000000.tx.124: Hum. 

Phrase: "Hum."
Processing 00000000.tx.125: Hered., 50, 133139.[ISI][Medline] 14 Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E. and Hutton, M. 

Phrase: "Hered.,"

Phrase: "50,"

Phrase: "133139."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 14 Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Litvan,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Adamson,"

Phrase: "J.,"

Phrase: "Dickson,"

Phrase: "D."

Phrase: ","

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Lynch,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bigio,"

Phrase: "E."

Phrase: "and"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.126: (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Association of an extended haplotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "in the tau gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "with progressive supranuclear palsy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]
Processing 00000000.tx.127: Hum. 

Phrase: "Hum."
Processing 00000000.tx.128: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.129: Genet., 8, 711715.[Abstract/Free FullText] 15 Touchman, J.W., Dehejia, A., Chiba-Falek, O., Cabin, D.E., Schwartz, J.R., Orrison, B.M., Polymeropoulos, M.H. and Nussbaum, R.L. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "711715."

Phrase: "[Abstract/Free FullText"

Phrase: "] 15 Touchman,"

Phrase: "J.W., Dehejia,"

Phrase: "A.,"

Phrase: "Chiba-Falek,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Cabin,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Schwartz,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Orrison,"

Phrase: "B.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]

Phrase: "Polymeropoulos,"

Phrase: "M."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.130: (2001) Human and mouse -synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "mouse -synuclein genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: ":"

Phrase: "comparative genomic sequence analysis"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   923   C0796358:comparative genomic analysis [Molecular Biology Research Technique]
   902   C0683941:comparative analysis [Research Activity]
   861   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C0936012:Analysis [Research Activity]
   812   C1519249:Sequence [Functional Concept]
   812   C1524024:analysis [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "identification of a novel gene regulatory element."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]
Processing 00000000.tx.131: Genome Res., 11, 7886.[Abstract/Free FullText] 16 Maraganore, D.M., Farrer, M.J., Hardy, J.A., Lincoln, S.J., McDonnell, S.K. and Rocca, W.A. 

Phrase: "Genome Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "11,"

Phrase: "7886."

Phrase: "[Abstract/Free FullText"

Phrase: "] 16 Maraganore,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Farrer,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Hardy,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Lincoln,"

Phrase: "S."

Phrase: "J.,"

Phrase: "McDonnell,"

Phrase: "S."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rocca,"

Phrase: "W."

Phrase: "A."
Processing 00000000.tx.132: (1999) Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinsons disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   775   C0007328:Case-Control Study [Research Activity]
   756   C0872128:case control [Health Care Activity]
   754   C0085973:Case Study [Intellectual Product]
   738   C0243148:control [Qualitative Concept]
   738   C0557651:Study [Manufactured Object]
   738   C0868928:Case [Functional Concept]
   738   C1550141:Control [Substance]
   738   C1706255:CASE [Medical Device]
   738   C1706256:Case [Conceptual Entity]
   738   C1882979:Control [Conceptual Entity]
   738   C2587213:Control [Functional Concept]
   738   C2603343:Study [Research Activity]
   738   C3274648:Control [Qualitative Concept]

Phrase: "in Parkinsons disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.133: Neurology, 53, 18581860.[Abstract/Free FullText] 17 Nickerson, D.A., Tobe, V.O. and Taylor, S.L. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "53,"

Phrase: "18581860."

Phrase: "[Abstract/Free FullText"

Phrase: "] 17 Nickerson,"

Phrase: "D.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tobe,"

Phrase: "V.O."

Phrase: "and"

Phrase: "Taylor,"

Phrase: "S.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.134: (1997) PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. 

Phrase: "(1997"

Phrase: ")"

Phrase: "PolyPhred"

Phrase: ":"

Phrase: "automating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1072074:automating [Eukaryote]

Phrase: "the detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "genotyping of single nucleotide substitutions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1285573:Genotyping [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescence-based resequencing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511693:Resequencing [Molecular Biology Research Technique]
Processing 00000000.tx.135: Nucleic Acids Res., 25, 27452751.[Abstract/Free FullText] 18 Antonarakis, S.E. 

Phrase: "Nucleic Acids Res.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "25,"

Phrase: "27452751."

Phrase: "[Abstract/Free FullText"

Phrase: "] 18 Antonarakis,"

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.136: (1998) Recommendations for a nomenclature system for human gene mutations. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Recommendations for a nomenclature system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034866:recommendations [Idea or Concept]

Phrase: "for human gene mutations."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0314604:Human gene [Gene or Genome]
   901   C0596611:gene mutations [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.137: Nomenclature Working Group. 

Phrase: "Nomenclature Working Group."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1883562:Working Group [Population Group]
   827   C0043227:Working [Occupational Activity]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
Processing 00000000.tx.138: Hum. 

Phrase: "Hum."
Processing 00000000.tx.139: Mutat., 11, 13.[ISI][Medline]

Phrase: "Mutat.,"

Phrase: "11,"

Phrase: "13."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

